Algernon Pharmaceuticals Inc. (OTCMKTS:AGNPF) Short Interest Update

Algernon Pharmaceuticals Inc. (OTCMKTS:AGNPF) was the target of a significant drop in short interest in October. As of October 31st, there was short interest totalling 4,200 shares, a drop of 49.4% from the October 15th total of 8,300 shares. Based on an average daily volume of 9,400 shares, the short-interest ratio is presently 0.4 days.

Algernon Pharmaceuticals Price Performance

Shares of Algernon Pharmaceuticals stock opened at $0.06 on Wednesday. The firm has a 50 day simple moving average of $0.06 and a 200 day simple moving average of $0.08. Algernon Pharmaceuticals has a fifty-two week low of $0.04 and a fifty-two week high of $0.12.

Algernon Pharmaceuticals Company Profile

Algernon Pharmaceuticals Inc operates as a clinical stage pharmaceutical development company. It focuses on the areas of non-alcoholic steatohepatitis, chronic kidney disease, inflammatory bowel disease, idiopathic pulmonary fibrosis, chronic cough, pancreatic and small cell lung cancer, and acute lung injury in Canada and Australia.